| scholarly article | Q13442814 |
| P2093 | author name string | ZVAIFLER NJ | |
| PEKIN TJ Jr | |||
| P2860 | cites work | Pathogenesis of serum sickness | Q74720452 |
| Serum complement in rheumatoid arthritis | Q75789943 | ||
| Significance of urate crystals in synovial fluids | Q76415698 | ||
| Complement, complement components, properdin and agglutination promoting factors in rheumatoid arthritis | Q78410845 | ||
| 1958 Revision of diagnostic criteria for rheumatoid arthritis | Q78419598 | ||
| Relationship of circulating antigen-antibody complexes, antigen elimination, and complement fixation in serum sickness | Q78441184 | ||
| Simple, rapid diagnostic test for rheumatoid arthritis; bentonite flocculation test | Q78477357 | ||
| Protein patterns in synovial fluid and serum in rheumatoid arthritis and osteoarthritis | Q78587201 | ||
| Comparative distribution of proteins and glycoproteins of serum and synovial fluid | Q78587206 | ||
| A study of the mechanism of the anticomplementary activity of gamma-globulin | Q78834506 | ||
| The significance of serum complement levels for the diagnosis and prognosis of acute and subacute glomerulonephritis and lupus erythematosus disseminatus | Q79053866 | ||
| Serum complement, rheumatoid factor, and other serum proteins in rheumatoid disease and systemic lupus erythematosus | Q33570749 | ||
| Immuno-electrophoretic Analysis of Proteins in Serum and Synovial Fluid in Rheumatoid Arthritis and Ankylosing Spondylitis | Q33570984 | ||
| Gamma globulin and complement in the diseased kidney | Q33941706 | ||
| Characterization of the proteins of human synovial fluid in certain disease states | Q35559992 | ||
| A comparative histologic and immunologic study in rabbits of induced hypersensitivity of the serum sickness type | Q36261970 | ||
| Role of gamma globulins in pathogenesis of renal lesions in systemic lupus erythematosus and chronic membranous glomerulonephritis, with an observation on the lupus erythematosus cell reaction | Q36263544 | ||
| The biological activity of soluble antigen-antibody complexes. II. Physical properties of soluble complexes having skin-irritating activity | Q36264099 | ||
| The pathologic effects of intravenously administered soluble antigen-antibody complexes. I. Passive serum sickness in mice | Q36264918 | ||
| The relationships between serum complement activity and the development of allergic lesions in rabbits | Q36334239 | ||
| STUDIES ON THE BACTERICIDAL PROPERTIES OF THE SYNOVIAL FLUID | Q40973871 | ||
| SEROLOGICAL STUDIES IN RHEUMATIC FEVER. II. SERUM COMPLEMENT IN THE RHEUMATIC STATE. | Q40999937 | ||
| Immunohistochemical study of lesions in rheumatic fever, systemic lupus ervthematosus, and rheumatoid arthritis | Q41015209 | ||
| Complementary activity of the blood in rheumatism and certain allied disorders | Q41341911 | ||
| The localization of in vivo bound complement in tissue section | Q42826669 | ||
| Serum complement in acute glomerulonephritis and other renal diseases. | Q51046791 | ||
| Precise Standardization of Reagents for Complement Fixation | Q53789356 | ||
| Permeability of the Synovial Membrane to Glycoproteins | Q58998084 | ||
| Serum complement in children with collagen diseases | Q73216537 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1372-1382 | |
| P577 | publication date | 1964-07-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | HEMOLYTIC COMPLEMENT IN SYNOVIAL FLUID. | |
| P478 | volume | 43 |
| Q37354195 | A broad screen for targets of immune complexes decorating arthritic joints highlights deposition of nucleosomes in rheumatoid arthritis |
| Q34681820 | A novel anti-inflammatory role for secretory phospholipase A2 in immune complex-mediated arthritis |
| Q67585359 | A study of complement fixation by rheumatoid factor using a haemolytic assay system |
| Q41134891 | Activation of the alternative pathway of complement by monosodium urate monohydrate crystals and other inflammatory particles. |
| Q34041472 | Activation of the complement and properdin systems in rheumatoid arthritis |
| Q71422720 | Agammaglobulinemia with polyarthritis and subcutaneous nodules |
| Q36457404 | An analysis of the levels of complement components in the synovial fluid in rheumatic diseases |
| Q70258140 | Anatomic separation of the suprapatellar pouch spares its involvement by rheumatoid synovitis in the knee |
| Q39390748 | Antibodies to native and denatured collagens in sera of patients with rheumatoid arthritis |
| Q39406225 | Antinuclear antibodies (ANA): Immunologic and clinical significance |
| Q47755287 | Antinuclear factors and chronic articular inflammation |
| Q39867274 | Appraisal of rheumatoid arthritis as an immune complex disease |
| Q36132380 | Aspects of science in Scandinavian rheumatology--the making of a specialty |
| Q41327999 | Behaviour of synovial complement C3 and C4 components in inflammatory and degenerative joint diseases, before and after synoviorthesis |
| Q35940411 | Biologic properties and detection of immune complexes in animal and human pathology |
| Q40473779 | Breakdown products of C 3 in human synovial fluids |
| Q70993588 | C1 inactivator-C1s complexes in inflammatory joint disease |
| Q39669558 | C3 Activation by Monosodium Urate Monohydrate and Other Crystalline Material |
| Q35201919 | C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase |
| Q41880059 | Catabolism and synovial transport of rheumatoid factor |
| Q42051015 | Circulating C3 is necessary and sufficient for induction of autoantibody-mediated arthritis in a mouse model |
| Q90241463 | Collagen Autoantibodies and Their Relationship to CCP Antibodies and Rheumatoid Factor in the Progression of Early Rheumatoid Arthritis |
| Q40328270 | Comparative morphology, respiration, and phagocytic function of leukocytes from blood and joint fluid in rheumatoid arthritis |
| Q35830260 | Complement C4-derived monocyte-directed chemotaxis-inhibitory factor. A molecular mechanism to cause polymorphonuclear leukocyte-predominant infiltration in rheumatoid arthritis synovial cavities. |
| Q33569703 | Complement and immunoglobulins in synovial fluid from synovectomized patients with rheumatoid arthritis |
| Q93803722 | Complement components in synovial fluid: activation and fixation in seropositive rheumatoid arthritis |
| Q41815427 | Complement fixation by a two-component antibody system: immunoglobulin G and immunoglobulin M anti-globulin (rheumatoid factor). Parodoxical effect related to immunoglobulin G concentration |
| Q39986124 | Complement in Rheumatoid Inflammation |
| Q40048136 | Complement in normal and disease processes |
| Q38016072 | Complement in the immunopathogenesis of rheumatic disease |
| Q33569147 | Complement metabolism in the seronegative arthritides |
| Q33580015 | Complement system in synovial fluids from patients with rheumatoid arthritis |
| Q34058258 | Complement-derived leukotactic factors in inflammatory synovial fluids of humans |
| Q33568264 | Complement-fixing activity of rheumatoid synovial fluid |
| Q41298938 | Corynebacterium acnes in rheumatoid arthritis. II. Identification of antigen in synovial fluid leucocytes |
| Q37641743 | Crystal-induced neutrophil activation |
| Q40157164 | Crystals and inflammation |
| Q38107014 | Current concepts of the mechanism of acute inflammation in gouty arthritis |
| Q42768802 | Depletion of alpha/beta T cells by a monoclonal antibody against the alpha/beta T cell receptor suppresses established adjuvant arthritis, but not established collagen-induced arthritis in rats |
| Q71618812 | Depression of synovial fluid complement activity and rheumatoid factor positivity |
| Q52488954 | Development and evaluation of a rapid, semi-automatic micro-method for CH50 estimation using a computer program. |
| Q70639765 | Evaluation of a latex slide test ("RA-test") for synovial fluid rheumatoid factor testing |
| Q33551324 | Examination of complement C3 metabolism in rheumatoid arthritis using 2-dimensional immunoelectrophoresis |
| Q33627057 | Exchange of IgM and albumin between plasma and synovial fluid in rheumatoid arthritis |
| Q71145250 | Further speculation on the pathogenesis of joint inflammation in rheumatoid arthritis |
| Q93692242 | Gamma globulin complexes in synovial fluids of patients with rheumatoid arthritis. Partial characterization and relationship to lowered complement levels |
| Q33551646 | Gold and penicillamine: a proposed mode of action in rheumatoid arthritis, based on synovial fluid analysis |
| Q41479880 | HEBERDEN ORATION, 1964. SOME IMMUNOLOGIC ASPECTS OF THE CONNECTIVE TISSUE DISEASES |
| Q54675861 | Haemolytic and Conglutinating Complement in Rheumatoid Synovial Fluid and Serum: Effect of Irradiation Synovectomy by Intra-articular Application of Radioactive Yttrium |
| Q41481398 | Haemolytic complement level and ragocyte (R A cell) concentration in synovial fluid |
| Q33568957 | High levels of serum complement factors in juvenille rheumatoid arthritis |
| Q70249518 | Ia specific antilymphocyte antibodies in rheumatoid arthritis |
| Q69021549 | IgE rheumatoid factors: quantification in synovial fluid and ability to induce synovial mast cell histamine release |
| Q40858449 | Immune complex-mediated rheumatic diseases: the evidence and the enigmas |
| Q35863255 | Immune complexes in human diseases: a review |
| Q44701354 | Immune complexes in rheumatoid synovitis: a mixed staining immunofluorescence study. |
| Q35195563 | Immune complexes in sera and synovial fluids of patients with rheumatoid arthritis. Radioimmunoassay with monocylonal rheumatoid factor |
| Q72345417 | Immunoconglutinin in various rheumatic diseases and certain diseases suspected of an autoimmune pathogenesis |
| Q39648520 | Immunoelectrophoretic assay for synovial fluid C3 with correction for synovial fluid globulin |
| Q35194257 | Immunoglobulins and complement components in synovial fluid of patients with acute rheumatic fever |
| Q41245366 | Immunoglobulins and complement in pleural effusions associated with bronchogenic carcinoma |
| Q40771000 | Immunohistochemical localization of prostaglandin e in rheumatoid synovial tissues |
| Q53749187 | Immunological properties of isolated IgG and IgM anti-gamma-globulins (rheumatoid factors) |
| Q71268651 | Immunological studies of an experimental chronic arthritis resembling rheumatoid arthritis |
| Q69967778 | Immunosuppressive therapy in the rheumatic diseases |
| Q90606204 | Impact of gut microbiota on gut-distal autoimmunity: a focus on T cells |
| Q34272996 | In vitro synthesis of immunoglobulin by rheumatoid synovial membrane |
| Q30525648 | Inflammatory gout: observations over a half-century |
| Q41338651 | Inhibition of Fc-rosette formation by synovial fluids from patients with rheumatoid arthritis |
| Q37638175 | Innate inflammation and resolution in acute gout |
| Q67442587 | Intraarticular activation of the complement system in patients with juvenile rheumatoid arthritis |
| Q41052614 | Investigation of rheumatic and connective tissue diseases |
| Q33557184 | Isolation and analysis of complement activating aggregates from synovial fluid of patients with rheumatoid arthritis using monoclonal anti-C3d antibodies |
| Q93812283 | Kappa:lambda light chain ratio in IgG eluted from rheumatoid arthritis synovium |
| Q79415988 | Mast cell-expressed complement receptor, not TLR2, is the main detector of zymosan in peritonitis |
| Q35844445 | Mast cells contribute to initiation of autoantibody-mediated arthritis via IL-1 |
| Q24798636 | Mast cells in inflammatory arthritis |
| Q33563013 | Measurement of the chemotactic complement fragment C5a in rheumatoid synovial fluids by radioimmunoassay: role of C5a in the acute inflammatory phase |
| Q36163163 | Mechanisms of inflammation in gout |
| Q74819720 | Membrane complement regulators protect against the development of type II collagen-induced arthritis in rats |
| Q37045869 | Metabolism of autologous and homologous IgG in rheumatoid arthritis |
| Q67448290 | Metabolism of factor B of serum complement in rheumatoid arthritis |
| Q38076334 | Neutrophils, IL-1β, and gout: is there a link? |
| Q39227459 | New knowledge of the pathogenesis of gout |
| Q64075091 | P2RX7 Deletion in T Cells Promotes Autoimmune Arthritis by Unleashing the Tfh Cell Response |
| Q71023663 | Proceedings of a symposium on crystal-related arthropathies. 22 October and 23 October, 1982, Bristol Polytechnic, Bristol |
| Q68804466 | Properties and reactivity of immune complexes in rheumatoid synovial fluid |
| Q51260199 | Protein synthesis in rheumatoid synovial tissue |
| Q36075753 | Regulation of complement by cartilage oligomeric matrix protein allows for a novel molecular diagnostic principle in rheumatoid arthritis |
| Q33569878 | Relation of titred peripheral pattern ANA to anti-DNA and disease activity in systemic lupus erythematosus |
| Q47811289 | Review: Genetics and the Classification of Arthritis in Adults and Children |
| Q40569829 | Rheumatoid Arthritis: A Dissertation on its Pathogenesis and Future Directions for Research* |
| Q55455212 | Rheumatoid arthritis. Surgical treatment |
| Q54065208 | Rheumatoid factor and the fixation of complement. |
| Q43627059 | Rheumatoid factor in synovial effusions: local production and consumption |
| Q40779873 | Rheumatoid factor plaque-forming cells in rheumatoid synovial tissue |
| Q41326843 | Rheumatoid synovitis and joint disease. Relationship between arthroscopic and histological changes |
| Q67773697 | Selective inhibition of lymphocyte responsiveness to phytohaemagglutinin in patients with Reiter's syndrome |
| Q93612718 | Simultaneous turnover of normal and dysfunctional C1 inhibitor as a probe of in vivo activation of C1 and contact activatable proteases |
| Q40663864 | Soluble deoxyribonucleoprotein (sNP) complexes in the pleural effusion of rheumatoid arthritis |
| Q40217274 | Soluble immune complexes in human disease |
| Q47761043 | Studies of isolated synovial lining cells of rheumatoid and nonrheumatoid synovial membranes |
| Q43241795 | Studies of the action of some anti-inflammatory drugs on complement mediated immune haemolysis |
| Q54668073 | Studies on the first component of complement (C1) and the inhibitor of C1 esterase in rheumatoid synovial fluids |
| Q41116603 | Survey of synovial fluid cryoprecipitates |
| Q72695104 | Symposium on the immunodiagnosis of rheumatic and related diseases, Part II. Rheumatoid factors |
| Q71630283 | Synovial fluid findings in systemic lupus erythematosus (SLE) |
| Q39590911 | The Biology and Detection of Immune Complexes |
| Q72061643 | The Clinical Significance of the RA Cell |
| Q39982272 | The Role of the Complement System in Rheumatoid Inflammation |
| Q54461894 | The effect of non-inflamed synovial fluid on neutrophil function in vitro. |
| Q39941762 | The immunopathology of joint inflammation in rheumatoid arthritis |
| Q44059765 | The joint-fluid gammaG-globulin complexes and their relationship to intraarticular complement dimunition |
| Q35671709 | The role of antibodies in mouse models of rheumatoid arthritis, and relevance to human disease |
| Q37399730 | Therapeutic effects of sesame oil on monosodium urate crystal-induced acute inflammatory response in rats |
| Q53749843 | Variation of killing power of human sera against Bordetella pertussis. |
| Q39971115 | Views on the Pathogenesis of Rheumatoid Arthritis |
| Q72089316 | [Circulating immune complexes and anti-IgG antibodies in rheumatoid disease. Value of C3d assay] |
Search more.